IBD & Intestinal Disorders
Conference Coverage
Azathioprine, anti-TNF monotherapy safe in IBD pregnancy
Key clinical point: Monotherapy with azathioprine and anti-TNF agents can be continued in pregnancy with IBD to maintain remission.Major finding:...
Conference Coverage
Norfloxacin reduced irritable bowel syndrome symptoms
Key clinical point: Norfloxacin was more effective than placebo was in reducing IBS symptoms, especially in patients with small intestinal...
From the AGA Journals
Phone calls offer ‘early warning’ in IBD
Major finding: Patients who frequently telephoned an IBD care center were also hospitalized at a rate that was 10 times greater than patients who...
From the AGA Journals
Ramosetron offers IBS-D alternative
Major finding: More than half of patients given ramosetron (50.3%) reported improved stool consistency after the first month of treatment,...
News
Etrolizumab leads to clinical remission in some patients with refractory ulcerative colitis
Key clinical point: The investigational antibody etrolizumab was linked to clinical remission in some patients with treatment-resistant ulcerative...
News
Integrin receptor antagonist approved for IBD, with postmarketing safety plans
Conference Coverage
Fecal transplant falls short in UC, but may not be the end
Key clinical finding: Fecal microbiota transplant is not ready for ulcerative colitis yet.Major finding: Remission was achieved by seven FMT...
News
Undiagnosed joint hypermobility syndrome prevalent in GI clinics
Major finding: Joint hypermobility syndrome is significantly associated with gastrointestinal symptoms such as abdominal pain, bloating, and...
Conference Coverage
Oral PPI therapy gets nod following bleeding ulcer repair
Major finding: Oral proton pump inhibitor therapy can safely and effectively replace the guideline-recommended standard regimen consisting of a...
Conference Coverage
Eluxadoline scores in phase III for irritable bowel syndrome
Major finding: Thirty-one percent of patients with diarrhea-predominant irritable bowel syndrome on 100 mg b.i.d.